Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Other Routine +

Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY

Restart Life Sciences Revenue Accelerates Post-Acquisition, Holy Crap Brand Shows Momentum

By The Northwire Desk — AI Analysis May 05, 2026 · 06:01 HEAL · 0.095 Restart Life Sciences Corp.
Executive Summary
  • Most recent release (May 5, 2026) reports April 2026 revenue of $106,288, a 34.2% increase year-over-year.
  • Wholesale revenue grew 45.6% YoY to $87,705; Amazon sales grew 32% YoY to $11,000.
  • Company maintains Canadian retail distribution network of over 800 locations.
  • Acquisition of Holy Crap Foods Inc. (closed Feb 27, 2026) is driving immediate revenue integration and growth momentum.
  • CEO Steve Loutskou states focus on gut health, functional nutrition, and consumer education is resonating in the marketplace.
  • Previous news confirms Walmart.ca listing (April 28), new protein SKU development (April 30), and 500,000 units sold milestone (April 23).
Material Impact
  • The revenue growth validates the acquisition strategy announced in February but absolute numbers remain small ($1.3M annualized run rate).
  • Growth is incremental rather than transformative; market likely anticipated this post-acquisition integration phase.
  • No new strategic investors or major capital raises mentioned in this specific release, limiting immediate valuation re-rating potential.
  • Positive confirmation of channel diversification (Amazon + Wholesale) reduces reliance on single sales channels.
  • Risk remains that revenue scale is insufficient to cover operational costs without further financing or significant margin improvement.
HEAL · Price
Company Overview
  • Company: Restart Life Sciences Corp. (CSE: HEAL).
  • Flagship Project: Holy Crap Foods Inc. acquired Feb 27, 2026.
  • Product Focus: Gut health, functional nutrition, clean-label cereals and snacks (Superseed, Oatmeal Variety Pack).
  • Development Stage: Commercial revenue generation; expanding distribution channels (Walmart.ca, Amazon) and product lines (Protein SKU).
  • Manufacturing: Lease-based plant in Gibsons, BC with blending/batching systems and trained personnel.
Read the original news release →

More from Restart Life Sciences Corp.

Jun 18, 2026 · 06:01

Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

Production / Operations Jun 10, 2026 · 08:01

Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch

Production / Operations Jun 03, 2026 · 06:01

Restart Life Sciences Taps CFO to Steer Holy Crap Foods' North American Expansion and Omnichannel Push

M&A / Property May 21, 2026 · 06:01

Restart Life Closes Financing as Revenue Growth Fails to Halt Stock Erosion

Financings May 15, 2026 · 16:00

Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio

Production / Operations May 13, 2026 · 06:01

Restart Life Sciences Expands U.S. Footprint via Amazon Logistics Amidst Modest Revenue Growth and Capital Dilution

Other